<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-04-14T08:26:55Z</responseDate><request verb="GetRecord" identifier="oai:www.recercat.cat:20.500.12327/4808" metadataPrefix="oai_dc">https://recercat.cat/oai/request</request><GetRecord><record><header><identifier>oai:recercat.cat:20.500.12327/4808</identifier><datestamp>2026-02-28T23:31:51Z</datestamp><setSpec>com_2072_4428</setSpec><setSpec>com_2072_4427</setSpec><setSpec>col_2072_487898</setSpec></header><metadata><oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:doc="http://www.lyncode.com/xoai" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
   <dc:title>Protection and diagnostic interference induced by heat-inactivated, phage-inactivated and live vaccine prototypes against animal tuberculosis</dc:title>
   <dc:creator>Fernández Veiga, Leire</dc:creator>
   <dc:creator>Fuertes, Miguel</dc:creator>
   <dc:creator>Geijo, María V.</dc:creator>
   <dc:creator>Elguezabal, Natalia</dc:creator>
   <dc:creator>Serrano-Mestre, Jose L.</dc:creator>
   <dc:creator>Vázquez-Iniesta, Lucía</dc:creator>
   <dc:creator>Prados-Rosales, Rafael</dc:creator>
   <dc:creator>Michelet, Lorraine</dc:creator>
   <dc:creator>Boschiroli, Maria Laura</dc:creator>
   <dc:creator>Pérez de Val, Bernat</dc:creator>
   <dc:creator>Jones, Gareth J.</dc:creator>
   <dc:creator>Juste, Ramón A.</dc:creator>
   <dc:creator>Garrido, Joseba M.</dc:creator>
   <dc:creator>Sevilla, Iker A.</dc:creator>
   <dc:contributor>Producció Animal</dc:contributor>
   <dc:contributor>Sanitat Animal</dc:contributor>
   <dc:subject>619</dc:subject>
   <dc:description>Introduction: Vaccination emerges as a promising cost-eective tool to reduce&#xd;
the impact and spread of animal tuberculosis, especially in regions where testand-slaughter eradication strategy is socioeconomically unfeasible or unfruitful&#xd;
for dierent reasons, provided it is safe, e cacious and compatible with&#xd;
diagnosis.&#xd;
Methods: In this study, we preliminarily evaluated the diagnostic interference&#xd;
(using guinea pigs) and the protective e cacy (using mice) of three heatinactivated, three phage-inactivated and one live attenuated vaccine prototypes&#xd;
prepared from M. bovis, M. caprae, and M. microti.&#xd;
Results and discussion: Phage-inactivation killed almost all (96.41–99.92%)&#xd;
bacteria to be included in vaccines and filtering was used to remove the&#xd;
remaining viable cells. All the assayed vaccines induced skin test reactions in&#xd;
response to bovine tuberculin, but they were smaller in the phage-inactivated&#xd;
vaccine groups. All the vaccines were diagnosis-compatible with defined skin&#xd;
test antigens based on ESAT-6, CFP-10, and Rv3615c. In contrast with the&#xd;
rest of prototypes, vaccination with heat- and phage-inactivated M. microti&#xd;
did not prompt the production of detectable anti-MPB70+MPB83 antibodies.&#xd;
Mean bacterial burden was lower in all vaccinated groups in comparison with&#xd;
the control, being significantly reduced in the lungs of the heat-inactivated M.&#xd;
microti and M. caprae and phage-inactivated M. caprae groups. Considering&#xd;
both diagnostic interference and protection collectively, the heat-inactivated M.&#xd;
microti vaccine showed the best performance. Further studies to evaluate these&#xd;
vaccines and to improve phage-driven inactivation are warranted.</dc:description>
   <dc:description>The author(s) declare that financial support was received for the research and/or publication of this article. This study has been carried out with funds from Grants PID2019-105155RB-C33 and PID2022-142939OR-C21 funded by MCIN/AEI/10.13039/501100011033 and by ERDF/EU, and Grant EFA115/01 INNOTUB II funded by the INTERREG POCTEFA 2021–2027 Program (co-funded by the European Union). LF-V holds a pre-doctoral fellowship from the Department of Economic Development, Sustainability and Environment of the Basque Government. RP-R thanks support from grants NIH RO1AI162821 and Spanish MICINN contracts PID2019-110240RB-I00 and PID2022-136611OB-I00.</dc:description>
   <dc:description>info:eu-repo/semantics/publishedVersion</dc:description>
   <dc:date>2025-07-21</dc:date>
   <dc:type>info:eu-repo/semantics/article</dc:type>
   <dc:identifier>Fernández-Veiga, Leire, Miguel Fuertes, María V Geijo, Natalia Elguezabal, Jose L Serrano-Mestre, Lucía Vázquez-Iniesta, Rafael Prados-Rosales, Bernat Pérez de Val, et al. 2025. “Protection and Diagnostic Interference Induced by Heat-inactivated, Phage-inactivated and Live Vaccine Prototypes Against Animal Tuberculosis.” Frontiers in Veterinary Science 12 (July). https://doi.org/10.3389/fvets.2025.1620497.</dc:identifier>
   <dc:identifier>2297-1769</dc:identifier>
   <dc:identifier>http://hdl.handle.net/20.500.12327/4808</dc:identifier>
   <dc:identifier>https://doi.org/10.3389/fvets.2025.1620497</dc:identifier>
   <dc:language>eng</dc:language>
   <dc:relation>Frontiers in Veterinary Science</dc:relation>
   <dc:relation>MICINN/Programa Estatal de generación del conocimiento y fortalecimiento científico y tecnológico del sistema I+D+I/PID2019- 105155RB-C33/ES/DEVELOPMENT OF INACTIVATED VACCINE PROTOTYPES FOR THE CONTROL OF TB IN DOMESTIC ANIMALS AND ASSESSMENT OF THE INTEREFERENCE CAUSED BY NON TUBERCULOUS ORGANISMS ON ITS DIAGNOSI/</dc:relation>
   <dc:relation>MICINN/Programa Estatal para Impulsar la Investigación Científico-Técnica y su Transferencia/PID2022-142939OR-C21/ES/DESARROLLO DE NUEVOS ABORDAJES DE VACUNACION MUCOSAL Y PARENTERAL FRENTE A LA TUBERCULOSIS ANIMAL Y EVALUACION DE SUS EFECTOS EN LOS MODELOS DE TUBERCULOSIS INTRANASAL DE RATO/</dc:relation>
   <dc:relation>EC/INTERREG-POCTEFA/EFA115-01/EU/Red transpirenaica de investigación y desarrollo de herramientas innovadoras para el control de la tuberculosis animal/INNOTUB II</dc:relation>
   <dc:relation>FEDER/ / /EU/ /</dc:relation>
   <dc:relation>MICINN/Programa Estatal de generación del conocimiento y fortalecimiento científico y tecnológico del sistema I+D+I/PID2019-110240RB-I00/ES/IDENTIFICACION DE VULNERABILIDADES EN MYCOBACTERIUM TUBERCULOSIS A TRAVES DE LA DISECCION GENETICA Y QUIMICA DEL PROCESO DE VESICULACION/</dc:relation>
   <dc:relation>MICINN/Programa Estatal para Impulsar la Investigación Científico-Técnica y su Transferencia/PID2022-136611OB-I00/ES/ IDENTIFICACION DE VULNERABILIDADES EN MYCOBACTERIUM TUBERCULOSIS A TRAVES DE LA DISECCION GENETICA Y QUIMICA DEL PROCESO DE VESICULACION/</dc:relation>
   <dc:rights>Attribution 4.0 International</dc:rights>
   <dc:rights>http://creativecommons.org/licenses/by/4.0/</dc:rights>
   <dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
   <dc:format>14</dc:format>
   <dc:publisher>Frontiers Media</dc:publisher>
</oai_dc:dc></metadata></record></GetRecord></OAI-PMH>